Pure Biologics

Pure Biologics Stock-Based Compensation

Stock-Based Compensation (SBC) of Pure Biologics (PUR.WA) as of Nov 12, 2026.

Stock-Based Compensation

0.00PLN

Last updated:

Stock-Based Compensation (SBC) of Pure Biologics is 2024 0.00 PLN. Stock-Based Compensation (SBC) of Pure Biologics was 2023 1.30 M PLN. It decreases by % lower compared to the previous year.

The Pure Biologics Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
10,000.00 PLN
Jan 1, 2020
3.75 M PLN
Jan 1, 2021
2.79 M PLN
Jan 1, 2022
4.41 M PLN
Jan 1, 2023
1.30 M PLN
Jan 1, 2024
0.00 PLN
The Pure Biologics Stock-Based Compensation history
YEARStock-Based CompensationYoY
0.00PLN-100.00%
1.30 MPLN-70.50%
4.41 MPLN+58.34%
2.79 MPLN-25.68%
3.75 MPLN+37,400.00%
10,000.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Pure Biologics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Pure Biologics